ADAG
Price
$1.43
Change
+$0.01 (+0.70%)
Updated
Apr 28 closing price
Capitalization
67.37M
29 days until earnings call
ENTA
Price
$5.63
Change
+$0.05 (+0.90%)
Updated
Apr 28 closing price
Capitalization
120.1M
13 days until earnings call
Ad is loading...

ADAG vs ENTA

Header iconADAG vs ENTA Comparison
Open Charts ADAG vs ENTABanner chart's image
Adagene
Price$1.43
Change+$0.01 (+0.70%)
Volume$17.27K
Capitalization67.37M
Enanta Pharmaceuticals
Price$5.63
Change+$0.05 (+0.90%)
Volume$110.34K
Capitalization120.1M
ADAG vs ENTA Comparison Chart
Loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAG vs. ENTA commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a StrongBuy and ENTA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (ADAG: $1.43 vs. ENTA: $5.63)
Brand notoriety: ADAG and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 57% vs. ENTA: 41%
Market capitalization -- ADAG: $67.37M vs. ENTA: $120.1M
ADAG [@Biotechnology] is valued at $67.37M. ENTA’s [@Biotechnology] market capitalization is $120.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than ADAG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 3 TA indicator(s) are bullish while ENTA’s TA Score has 5 bullish TA indicator(s).

  • ADAG’s TA Score: 3 bullish, 4 bearish.
  • ENTA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ENTA is a better buy in the short-term than ADAG.

Price Growth

ADAG (@Biotechnology) experienced а -7.74% price change this week, while ENTA (@Biotechnology) price change was +7.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.96%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -9.88%.

Reported Earning Dates

ADAG is expected to report earnings on Aug 27, 2025.

ENTA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($120M) has a higher market cap than ADAG($67.4M). ENTA YTD gains are higher at: -2.087 vs. ADAG (-28.141). ADAG has higher annual earnings (EBITDA): -31.51M vs. ENTA (-94.42M). ENTA has more cash in the bank: 217M vs. ADAG (95.7M). ADAG has less debt than ENTA: ADAG (20.8M) vs ENTA (57.5M). ENTA has higher revenues than ADAG: ENTA (66.6M) vs ADAG (816K).
ADAGENTAADAG / ENTA
Capitalization67.4M120M56%
EBITDA-31.51M-94.42M33%
Gain YTD-28.141-2.0871,348%
P/E RatioN/AN/A-
Revenue816K66.6M1%
Total Cash95.7M217M44%
Total Debt20.8M57.5M36%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGENTA
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 6 days ago
69%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 22 days ago
83%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
56%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NINOY10.240.11
+1.09%
Nikon Corp.
AAAVX12.10N/A
N/A
DWS RREEF Real Assets R6
VLNPX36.73N/A
N/A
Voya Small Cap Growth R6
ABVAX16.13N/A
N/A
AB Large Cap Value A
BBKCF0.08N/A
N/A
BIGG Digital Assets Inc.

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and ENTA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and ENTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
+0.70%
ENTA - ADAG
25%
Poorly correlated
+0.90%
IBO - ADAG
25%
Poorly correlated
+1.50%
CRDF - ADAG
23%
Poorly correlated
+2.43%
CYBN - ADAG
22%
Poorly correlated
-1.72%
IGC - ADAG
22%
Poorly correlated
-0.90%
More

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ADCT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ADCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+0.90%
ADCT - ENTA
37%
Loosely correlated
+9.77%
ALEC - ENTA
36%
Loosely correlated
+1.75%
BEAM - ENTA
36%
Loosely correlated
+1.43%
PRME - ENTA
36%
Loosely correlated
-1.78%
CLRB - ENTA
35%
Loosely correlated
-4.39%
More